Glucose– tag –
-
Flexible Wearable Electrochemical Glucose Sensor Developed for Sweat Analyte Sensing: Advancing Non-Invasive Monitoring
IEEE Xplore Unknown Overview A flexible, screen-printed electrochemical glucose sensor for wearable sweat monitoring has been developed, combining high conductivity with excellent mechanical conformability through optimized conductive in... -
Dexcom Achieves 13% Q2 Revenue Growth as FDA Approves OTC Glucose Biosensor Stelo for Pediatric Use
Medical Design and Outsourcing USA Overview Dexcom reported a robust 13% year-over-year revenue growth in Q2 2026, demonstrating the efficacy of its CGM technology in non-insulin-using Type 2 diabetes patients. Concurrently, the U.S. FDA... -
Wellness CGMs Under Scrutiny: Long-Term Benefits for Non-Diabetics Lack Robust Clinical Evidence
The European Sting Belgium Overview A recent systematic review in the Journal of Medical Internet Research questions the long-term clinical efficacy of continuous glucose monitors (CGMs) for non-diabetics. While CGMs show promise in prom... -
MIT’s Non-Invasive Raman-Based CGM Achieves Accuracy Comparable to Commercial Devices, Signaling Next-Generation Glucose Monitoring Potential
Morld USA Overview MIT researchers have developed a novel Raman-based non-invasive continuous glucose monitoring (CGM) device that reads glucose through the skin without needles. Initial tests demonstrate accuracy comparable to existing ... -
Medtronic Launches Simplera Sync CGM Sensor in South Korea, Streamlining Glucose Management for MiniMed 780G Users
KBR South Korea Overview Medtronic has launched its Simplera Sync Sensor, a new continuous glucose monitoring (CGM) device, in South Korea for users of the MiniMed 780G automated insulin delivery (AID) system. This all-in-one disposable ... -
Dexcom Expands Beyond Diabetes Sensors to Comprehensive Health Platform with G8 Launch, Stelo Introduction, and FDA TEMPO Program Inclusion
Libre Life USA Overview Dexcom is transforming from a diabetes sensor manufacturer into a broader connected health platform, marked by the announcement of its next-gen G8 CGM, a 15-day wear extension for G7 internationally, and the launc... -
FDA Clears Dexcom’s Stelo Glucose Biosensor System as First OTC Continuous Glucose Monitor for Non-Insulin-Using Children Ages 2+
Weence.com USA Overview On June 12, 2026, the FDA approved Dexcom's Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM) for children aged 2 and older who do not use insulin. This system, wh... -
DexCom Reports Strong Q2 2026 Results with 13% Revenue Growth, 50% Operating Income Surge
Stock Titan USA Overview DexCom announced robust Q2 2026 financial results, with revenue up 13% year-over-year, driven by increased disposable sensor volumes and an expanding customer base. The company also reported a significant 50% ris... -
Dexcom G7 Achieves Industry-Leading Accuracy with MARD 8.2-8.5% in Adults, Clinical Data Confirms
diabetesknow.com USA Overview Newly compiled clinical data for 2026 ranks the Dexcom G7 as the most accurate continuous glucose monitor (CGM), reporting a mean absolute relative difference (MARD) of approximately 8.2–8.5% in adults. This... -
MedWatch Technologies Secures $15 Million in Series A Funding for Non-Invasive Glucose Biosensor and Lifestyle Coaching Platform
Cure USA Overview MedWatch Technologies has secured $15 million in Series A financing to accelerate the development of its non-invasive biosensor for glucose-related insights and an integrated lifestyle coaching platform. This capital in...
